RACHEL BOWERS: Open Payments
NPI 1093743510 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,547 in 85 payments from 20 companies in 2025. Trend: 2023 $5,766 · 2024 $5,216 · 2025 $6,547
Speaker / faculty: $2,848Food & beverage: $2,126Travel & lodging: $1,473Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $4,836 |
| Boston Scientific Corporation | 3 | $282 |
| Janssen Biotech, Inc. | 7 | $262 |
| Astellas Pharma US Inc | 8 | $201 |
| ACCORD HEALTHCARE, INC. | 9 | $174 |
| Dendreon Pharmaceuticals LLC | 5 | $141 |
| Sumitomo Pharma America, Inc. | 4 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| 180 Medical, Inc. | 4 | $64 |
| UROGEN PHARMA, INC. | 2 | $56 |
Products named: BOTOX, ERLEADA, Axonics, XTANDI, Camcevi, PROVENGE, GEMTESA, Nubeqa.
Industry payments across NV — which companies pay providers there.
